Theranautilus is a deep-tech startup that develops professional robots for the dental industry. The company raised 1.2 million USD in its ongoing seed funding round. Pi Ventures led the funding round with the participation of Golden Sparrow Ventures. The angel investors including the CEO of tracxn., CEO of Groww, and Abhishek Goyal also participated in the funding round.
The startup plans to use these fresh proceeds to scale its innovative technology beyond dental applications, enhance its platform, improve its production capability, and develop a go-to-market strategy. The report from Entrackr mentioned that the startup also intends to use this investment to commercialize nanorobotics-based medical devices for dental care applications. The company previously secured $60.3k from the Indian Institute of Technology Roorkee during its seed funding round in 2023.
Theranautilus offers robotic solutions for critical dental health challenges. The firm uses advanced technology to develop innovative nanorobotic solutions and transform issues like dental hypersensitivity which affects over 2 billion people globally and represents a $6 billion market according to a report by Entrackr. The firm also plans to introduce new services and increase its efficiency while extending innovative technology. This investment round highlights investors’ trust in Theranautilus’s market potential and business model.
The Bengaluru-based company allows users to solve dental-related problems like root canal treatment, tooth fracture, decay, and more. The startup has already developed nanobots including TheraDrive and BioBots. These nanobots with precision-manufactured nanobots offer long-term solutions to targeted locations within dental tissue and deliver biocompatible materials. After getting triggered to repair the damaged tissue, the products have to form a bio-mimetic structure.
The company wants to provide dental companies with robotics solutions to commercialize precision theranostics-based interventions to manage several diseases including cancer therapy. This fresh capital will enhance the performance capability and allow the firm to develop more innovative robotics solutions. The company uses artificial intelligence and advanced technologies to provide a seamless user experience.
The company has been working on several new products for dental line applications. The development came just after the deep tech market segment saw increased investor interest. The company plans to use a portion of this investment to expand its customer base while expanding its offerings. Theranautilus faces competition from other deep tech companies offering robotics solutions for dental industry purposes such as DentistRobot, Neocis, and Perceptive.
Conclusion :
Theranautilus is a deep tech startup offering robotics solutions for the dental industry. The company recently raised 1.2 million USD in its seed funding round from Pi Ventures, Golden Sparrow Ventures, and other angel investors. The company intends to use this amount to commercialize its medical devices based on nanorobotics, advance its efforts, enhance its research, and extend its offerings.
The Bengaluru-based startup aims to provide robotics solutions for multiple dental-related purposes like dental hypersensitivity and other diseases like cancer therapy. The funding round came just after the deep tech firm saw increased investor interest. The company offers nanobots like TheraDrive and competes with other deep tech firms including Neocis and Dentist Robot.
Hi, This is Scoopearth’s admin profile. Scoopearth is a well-known Digital Media Platform. We share Very Authentic and Meaningful information based on Real facts and Verification related to start-ups, technology, Digital Marketing, Business and Finance.
Note: You can reach us at support@scoopearth.com with any further queries.
Linkedin Page : https://www.linkedin.com/company/scoopearth-com/
Disclaimer -We have collected this information from our direct sources, various trustworthy sources on the internet and the facts have been checked manually and verified by our in-house team.
0 Comments